Phathom Pharmaceuticals
PHAT
PHAT
110 hedge funds and large institutions have $453M invested in Phathom Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.75%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
15
Increased
48
Reduced
24
Closed
7
Calls
$1.62M
Puts
$326K
Net Calls
+$1.29M
Net Calls Change
-$4.25M
Top Buyers
| 1 |
1
BlackRock
New York
|
$25.3M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$2.86M |
| 3 |
GGHC
3
Gilder Gagnon Howe & Co
New York
|
$13.6M |
| 4 |
GTC
4
Ghost Tree Capital
New York
|
$4.1M |
| 5 |
5
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$2.91M |
